PLD1 expression is inversely correlated with the levels of E2F1 target genes in the survival of CRC patients; thus, PLD1 and E2F1 might be potential prognostic biomarkers and therapeutic targets in CRC. This evidence concerns the gene E2F1 and colorectal carcinoma.